SynthesisLeukemia2025

The impact of high-risk cytogenetics on treatment efficacy and outcomes of patients with relapsed/refractory multiple myeloma: a systematic review and meta-analysis of randomized controlled trials.

Ioannis Ntanasis-Stathopoulos et al.PubMed ↗Publisher ↗

No numbers read from the abstract.